Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision marker was updated from v3.5.3 to v3.5.4. This indicates a newer version of the page's documentation/template rather than a modification to trial details or results.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version release without changing the study details presented on the page.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3. This is a metadata revision and does not affect the study information.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded Revision: v3.4.2. Removed the Revision: v3.4.1 notice regarding government funding status.SummaryDifference0.4%

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.